Approval · Notice of Compliance 4142 · 1997
LAMISIL: Notice of Compliance 4142
Issued February 6, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4142
- Date
- February 6, 1997
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New regimen: one week dosing regimen in the treatment of t. corporis/cruris and c.albicans
- Therapeutic class
- Antifungal agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LAMISIL | Not yet assigned | — |
Medicinal ingredients
- TERBINAFINE HCL 1 PER